Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.27
AET's Cash to Debt is ranked higher than
69% of the 42 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.53 vs. AET: 0.27 )
AET' s 10-Year Cash to Debt Range
Min: 0.23   Max: 35.48
Current: 0.27

0.23
35.48
Equity to Asset 0.27
AET's Equity to Asset is ranked higher than
62% of the 45 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.38 vs. AET: 0.27 )
AET' s 10-Year Equity to Asset Range
Min: 0.09   Max: 0.28
Current: 0.27

0.09
0.28
Interest Coverage 12.92
AET's Interest Coverage is ranked higher than
74% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.20 vs. AET: 12.92 )
AET' s 10-Year Interest Coverage Range
Min: 0.84   Max: 20.98
Current: 12.92

0.84
20.98
F-Score: 7
Z-Score: 2.07
M-Score: -2.47
WACC vs ROIC
5.53%
11.61%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating margin (%) 7.33
AET's Operating margin (%) is ranked higher than
84% of the 45 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.47 vs. AET: 7.33 )
AET' s 10-Year Operating margin (%) Range
Min: -0.94   Max: 11.45
Current: 7.33

-0.94
11.45
Net-margin (%) 3.52
AET's Net-margin (%) is ranked higher than
84% of the 45 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.36 vs. AET: 3.52 )
AET' s 10-Year Net-margin (%) Range
Min: -12.85   Max: 11.28
Current: 3.52

-12.85
11.28
ROE (%) 14.09
AET's ROE (%) is ranked higher than
86% of the 44 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.62 vs. AET: 14.09 )
AET' s 10-Year ROE (%) Range
Min: -30.14   Max: 26.4
Current: 14.09

-30.14
26.4
ROA (%) 3.90
AET's ROA (%) is ranked higher than
84% of the 45 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.79 vs. AET: 3.90 )
AET' s 10-Year ROA (%) Range
Min: -6.13   Max: 5.4
Current: 3.9

-6.13
5.4
ROC (Joel Greenblatt) (%) 617.41
AET's ROC (Joel Greenblatt) (%) is ranked higher than
95% of the 44 Companies
in the Global Health Care Plans industry.

( Industry Median: 166.44 vs. AET: 617.41 )
AET' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -65.8   Max: 1154.77
Current: 617.41

-65.8
1154.77
Revenue Growth (3Y)(%) 22.00
AET's Revenue Growth (3Y)(%) is ranked higher than
83% of the 41 Companies
in the Global Health Care Plans industry.

( Industry Median: 15.20 vs. AET: 22.00 )
AET' s 10-Year Revenue Growth (3Y)(%) Range
Min: -15.7   Max: 22
Current: 22

-15.7
22
EBITDA Growth (3Y)(%) 7.80
AET's EBITDA Growth (3Y)(%) is ranked higher than
76% of the 38 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.60 vs. AET: 7.80 )
AET' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0   Max: 76.8
Current: 7.8

0
76.8
EPS Growth (3Y)(%) 2.90
AET's EPS Growth (3Y)(%) is ranked higher than
81% of the 37 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.00 vs. AET: 2.90 )
AET' s 10-Year EPS Growth (3Y)(%) Range
Min: -12.9   Max: 63.9
Current: 2.9

-12.9
63.9
» AET's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

AET Guru Trades in Q1 2014

Larry Robbins 5,366,213 sh (+195.59%)
Joel Greenblatt 6,886 sh (+93.1%)
HOTCHKIS & WILEY 868,000 sh (+17.84%)
Richard Pzena 776,431 sh (+5.79%)
David Dreman 5,665 sh (+2.72%)
John Buckingham 113,113 sh (+0.92%)
Pioneer Investments 2,592,082 sh (+0.17%)
Vanguard Health Care Fund 5,936,383 sh (unchged)
Dodge & Cox 6,000 sh (unchged)
Jeff Auxier 5,239 sh (unchged)
Jim Simons Sold Out
John Paulson 7,989,506 sh (-0.08%)
John Hussman 250,000 sh (-7.41%)
David Einhorn 3,220,440 sh (-25%)
Paul Tudor Jones 6,613 sh (-32.52%)
Jeremy Grantham 169,271 sh (-54.5%)
Ray Dalio 30,919 sh (-60.47%)
Steven Cohen 19,744 sh (-94.27%)
» More
Q2 2014

AET Guru Trades in Q2 2014

Louis Moore Bacon 5,326 sh (New)
Paul Tudor Jones 9,100 sh (+37.61%)
Vanguard Health Care Fund 7,195,883 sh (+21.22%)
Joel Greenblatt 7,811 sh (+13.43%)
Ray Dalio 34,219 sh (+10.67%)
David Dreman 6,247 sh (+10.27%)
Richard Pzena 824,931 sh (+6.25%)
John Buckingham 113,229 sh (+0.1%)
Steven Cohen 41,400 sh (unchged)
Dodge & Cox 6,000 sh (unchged)
David Einhorn 3,220,440 sh (unchged)
John Paulson 7,989,506 sh (unchged)
Jeff Auxier 5,239 sh (unchged)
Pioneer Investments 2,544,081 sh (-1.85%)
HOTCHKIS & WILEY 849,400 sh (-2.14%)
John Hussman 175,000 sh (-30%)
Larry Robbins 3,478,835 sh (-35.17%)
Jeremy Grantham 75,265 sh (-55.54%)
» More
Q3 2014

AET Guru Trades in Q3 2014

Paul Tudor Jones 23,955 sh (+163.24%)
Larry Robbins 4,400,035 sh (+26.48%)
Joel Greenblatt 8,947 sh (+14.54%)
Ray Dalio 36,919 sh (+7.89%)
Richard Pzena 864,356 sh (+4.78%)
David Dreman 6,321 sh (+1.18%)
Dodge & Cox 6,000 sh (unchged)
Jeff Auxier 5,239 sh (unchged)
John Hussman 175,000 sh (unchged)
Pioneer Investments 2,461,350 sh (unchged)
Louis Moore Bacon Sold Out
Steven Cohen Sold Out
John Buckingham 111,951 sh (-1.13%)
John Paulson 7,794,638 sh (-2.44%)
Vanguard Health Care Fund 6,869,583 sh (-4.53%)
HOTCHKIS & WILEY 801,700 sh (-5.62%)
David Einhorn 3,009,188 sh (-6.56%)
Jeremy Grantham 5,197 sh (-93.1%)
» More
Q4 2014

AET Guru Trades in Q4 2014

Jim Simons 126,490 sh (New)
Joel Greenblatt 45,923 sh (+413.28%)
Vanguard Health Care Fund 7,119,383 sh (+3.64%)
Richard Pzena 882,256 sh (+2.07%)
Jeff Auxier 5,314 sh (+1.43%)
Pioneer Investments 2,463,870 sh (+0.1%)
Dodge & Cox 6,000 sh (unchged)
John Hussman 175,000 sh (unchged)
John Paulson Sold Out
HOTCHKIS & WILEY 798,600 sh (-0.39%)
John Buckingham 111,476 sh (-0.42%)
David Dreman 6,004 sh (-5.02%)
Paul Tudor Jones 22,499 sh (-6.08%)
Ray Dalio 34,519 sh (-6.5%)
Larry Robbins 3,960,125 sh (-10%)
Jeremy Grantham 3,031 sh (-41.68%)
David Einhorn 1,349,551 sh (-55.15%)
» More
» Details

Insider Trades

Latest Guru Trades with AET

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
John Paulson 2014-12-31 Sold Out 2.6%$73.43 - $90.84 $ 99.7919%0
David Einhorn 2014-12-31 Reduce -55.15%1.93%$73.43 - $90.84 $ 99.7919%1349551
Joel Greenblatt 2014-12-31 Add 413.28%0.03%$73.43 - $90.84 $ 99.7919%45923
David Einhorn 2014-09-30 Reduce -6.56%0.24%$75.22 - $84.94 $ 99.7922%3009188
John Hussman 2014-06-30 Reduce -30%0.42%$67.77 - $82.46 $ 99.7932%175000
Vanguard Health Care Fund 2014-06-30 Add 21.22%0.26%$67.77 - $82.46 $ 99.7932%7195883
David Einhorn 2014-03-31 Reduce -25%1%$65.15 - $75.71 $ 99.7941%3220440
Ray Dalio 2014-03-31 Reduce -60.47%0.03%$65.15 - $75.71 $ 99.7941%30919
Joel Greenblatt 2014-03-31 Add 93.1%$65.15 - $75.71 $ 99.7941%6886
David Einhorn 2013-12-31 Reduce -22.63%1.43%$60.75 - $68.93 $ 99.7953%4293940
John Hussman 2013-12-31 Reduce -32.5%0.46%$60.75 - $68.93 $ 99.7953%270000
Andreas Halvorsen 2013-12-31 Sold Out 0.06%$60.75 - $68.93 $ 99.7953%0
David Einhorn 2013-09-30 Reduce -17.52%1.4%$61.54 - $68.71 $ 99.7956%5550040
HOTCHKIS & WILEY 2013-09-30 Reduce -73.65%0.66%$61.54 - $68.71 $ 99.7956%747800
John Paulson 2013-09-30 Add 22.91%0.62%$61.54 - $68.71 $ 99.7956%7997107
Richard Pzena 2013-09-30 Reduce -62.94%0.54%$61.54 - $68.71 $ 99.7956%754946
Mark Hillman 2013-09-30 Reduce -22.7%0.34%$61.54 - $68.71 $ 99.7956%13306
Andreas Halvorsen 2013-09-30 Reduce -84.9%0.31%$61.54 - $68.71 $ 99.7956%160076
David Dreman 2013-09-30 Reduce -87.08%0.06%$61.54 - $68.71 $ 99.7956%5135
Ray Dalio 2013-09-30 Add 142.59%0.02%$61.54 - $68.71 $ 99.7956%74177
Joel Greenblatt 2013-09-30 Reduce -54.95%0.01%$61.54 - $68.71 $ 99.7956%4058
Mark Hillman 2013-06-30 New Buy1.5%$52.38 - $63.59 $ 99.7970%17213
John Hussman 2013-06-30 New Buy1.2%$52.38 - $63.59 $ 99.7970%400000
Vanguard Health Care Fund 2013-06-30 Add 33.47%0.38%$52.38 - $63.59 $ 99.7970%6239883
David Einhorn 2013-06-30 Add 3.39%0.26%$52.38 - $63.59 $ 99.7970%6728940
Joel Greenblatt 2013-06-30 Reduce -77.61%0.08%$52.38 - $63.59 $ 99.7970%9008
Ray Dalio 2013-06-30 New Buy0.02%$52.38 - $63.59 $ 99.7970%30577
David Dreman 2013-06-30 Reduce -25.37%0.02%$52.38 - $63.59 $ 99.7970%39735
Mark Hillman 2013-03-31 Sold Out 0.79%$44.38 - $51.46 $ 99.79106%0
HOTCHKIS & WILEY 2013-03-31 Add 297.22%0.6%$44.38 - $51.46 $ 99.79106%3080800
John Paulson 2013-03-31 Add 44.44%0.58%$44.38 - $51.46 $ 99.79106%6500000
Vanguard Health Care Fund 2013-03-31 Add 90.82%0.45%$44.38 - $51.46 $ 99.79106%4675200
Richard Pzena 2013-03-31 Add 153.01%0.42%$44.38 - $51.46 $ 99.79106%1953905
Andreas Halvorsen 2013-03-31 New Buy0.39%$44.38 - $51.46 $ 99.79106%1284000
David Einhorn 2012-12-31 Add 48.04%1.53%$40.7 - $46.99 $ 99.79129%6508215
John Paulson 2012-12-31 New Buy1.3%$40.7 - $46.99 $ 99.79129%4500000
John Burbank 2012-12-31 Sold Out 0.76%$40.7 - $46.99 $ 99.79129%0
Richard Pzena 2012-12-31 New Buy0.29%$40.7 - $46.99 $ 99.79129%772250
David Dreman 2012-12-31 Reduce -78.32%0.21%$40.7 - $46.99 $ 99.79129%58946
Ray Dalio 2012-12-31 Sold Out 0.04%$40.7 - $46.99 $ 99.79129%0
Daniel Loeb 2012-09-30 Sold Out 1.1%$35.3 - $39.9 $ 99.79162%0
David Einhorn 2012-09-30 Add 38.69%0.81%$35.3 - $39.9 $ 99.79162%4396255
John Burbank 2012-09-30 New Buy0.76%$35.3 - $39.9 $ 99.79162%420400
Mark Hillman 2012-09-30 New Buy0.59%$35.3 - $39.9 $ 99.79162%6013
John Hussman 2012-09-30 Sold Out 0.47%$35.3 - $39.9 $ 99.79162%0
HOTCHKIS & WILEY 2012-09-30 New Buy0.18%$35.3 - $39.9 $ 99.79162%777100
David Dreman 2012-09-30 Reduce -29.37%0.1%$35.3 - $39.9 $ 99.79162%271916
Joel Greenblatt 2012-09-30 Add 65.09%0.04%$35.3 - $39.9 $ 99.79162%40262
Ray Dalio 2012-09-30 Add 67.81%0.01%$35.3 - $39.9 $ 99.79162%67604
David Einhorn 2012-06-30 New Buy1.9%$39.65 - $50.39 $ 99.79128%3169925
Daniel Loeb 2012-06-30 New Buy1.1%$39.65 - $50.39 $ 99.79128%900000
Lee Ainslie 2012-06-30 Sold Out 0.81%$39.65 - $50.39 $ 99.79128%0
Andreas Halvorsen 2012-06-30 Sold Out 0.19%$39.65 - $50.39 $ 99.79128%0
Joel Greenblatt 2012-06-30 Add 51.82%0.02%$39.65 - $50.39 $ 99.79128%24388
Ray Dalio 2012-06-30 Add 386.19%0.02%$39.65 - $50.39 $ 99.79128%40286
George Soros 2012-06-30 Sold Out 0.0047%$39.65 - $50.39 $ 99.79128%0
John Keeley 2012-06-30 Sold Out 0.0041%$39.65 - $50.39 $ 99.79128%0
Lee Ainslie 2012-03-31 New Buy0.81%$42.4 - $50.39 $ 99.79137%1129430
Richard Pzena 2012-03-31 Sold Out 0.35%$42.4 - $50.39 $ 99.79137%0
Andreas Halvorsen 2012-03-31 New Buy0.19%$42.4 - $50.39 $ 99.79137%472020
Joel Greenblatt 2012-03-31 Add 127.96%0.04%$42.4 - $50.39 $ 99.79137%16064
Ray Dalio 2012-03-31 Reduce -79.17%0.02%$42.4 - $50.39 $ 99.79137%8286
John Keeley 2012-03-31 New Buy$42.4 - $50.39 $ 99.79137%4030
George Soros 2012-03-31 New Buy$42.4 - $50.39 $ 99.79137%6400
John Hussman 2011-12-31 Add 50%0.17%$34.33 - $43.73 $ 99.79153%750000
George Soros 2011-12-31 Sold Out 0.06%$34.33 - $43.73 $ 99.79153%0
Ray Dalio 2011-12-31 Reduce -57.58%0.03%$34.33 - $43.73 $ 99.79153%39786
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 17.60
AET's P/E(ttm) is ranked higher than
92% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 28.10 vs. AET: 17.60 )
AET' s 10-Year P/E(ttm) Range
Min: 5.41   Max: 20.07
Current: 17.6

5.41
20.07
Forward P/E 12.61
AET's Forward P/E is ranked higher than
98% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 15.75 vs. AET: 12.61 )
N/A
PE(NRI) 17.60
AET's PE(NRI) is ranked higher than
92% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 28.10 vs. AET: 17.60 )
AET' s 10-Year PE(NRI) Range
Min: 5.41   Max: 20.07
Current: 17.6

5.41
20.07
P/B 2.40
AET's P/B is ranked higher than
80% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.95 vs. AET: 2.40 )
AET' s 10-Year P/B Range
Min: 0.88   Max: 2.94
Current: 2.4

0.88
2.94
P/S 0.60
AET's P/S is ranked higher than
72% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.64 vs. AET: 0.60 )
AET' s 10-Year P/S Range
Min: 0.29   Max: 1.4
Current: 0.6

0.29
1.4
PFCF 12.00
AET's PFCF is ranked higher than
88% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.09 vs. AET: 12.00 )
AET' s 10-Year PFCF Range
Min: 4.49   Max: 60.1
Current: 12

4.49
60.1
POCF 10.66
AET's POCF is ranked higher than
84% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.89 vs. AET: 10.66 )
AET' s 10-Year POCF Range
Min: 3.68   Max: 31.67
Current: 10.66

3.68
31.67
EV-to-EBIT 8.50
AET's EV-to-EBIT is ranked higher than
90% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.50 vs. AET: 8.50 )
AET' s 10-Year EV-to-EBIT Range
Min: -1.3   Max: 11.1
Current: 8.5

-1.3
11.1
PEG 1.21
AET's PEG is ranked higher than
96% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.87 vs. AET: 1.21 )
AET' s 10-Year PEG Range
Min: 0.25   Max: 1.44
Current: 1.21

0.25
1.44
Shiller P/E 20.80
AET's Shiller P/E is ranked higher than
92% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 38.08 vs. AET: 20.80 )
AET' s 10-Year Shiller P/E Range
Min: 5.82   Max: 130.18
Current: 20.8

5.82
130.18
Current Ratio 0.77
AET's Current Ratio is ranked higher than
65% of the 37 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.37 vs. AET: 0.77 )
AET' s 10-Year Current Ratio Range
Min: 0.65   Max: 2.78
Current: 0.77

0.65
2.78
Quick Ratio 0.77
AET's Quick Ratio is ranked higher than
65% of the 37 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.37 vs. AET: 0.77 )
AET' s 10-Year Quick Ratio Range
Min: 0.65   Max: 2.78
Current: 0.77

0.65
2.78
Days Sales Outstanding 30.76
AET's Days Sales Outstanding is ranked higher than
84% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 29.38 vs. AET: 30.76 )
AET' s 10-Year Days Sales Outstanding Range
Min: 11.62   Max: 32.52
Current: 30.76

11.62
32.52

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.90
AET's Dividend Yield is ranked lower than
62% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.03 vs. AET: 0.90 )
AET' s 10-Year Dividend Yield Range
Min: 0.02   Max: 1.77
Current: 0.9

0.02
1.77
Dividend Payout 0.16
AET's Dividend Payout is ranked higher than
90% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.00 vs. AET: 0.16 )
AET' s 10-Year Dividend Payout Range
Min: 0   Max: 0.16
Current: 0.16

0
0.16
Dividend growth (3y) 26.00
AET's Dividend growth (3y) is ranked higher than
94% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 31.80 vs. AET: 26.00 )
AET' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 171.4
Current: 26

0
171.4
Yield on cost (5-Year) 36.84
AET's Yield on cost (5-Year) is ranked higher than
96% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.59 vs. AET: 36.84 )
AET' s 10-Year Yield on cost (5-Year) Range
Min: 0.82   Max: 72.46
Current: 36.84

0.82
72.46
Share Buyback Rate 1.90
AET's Share Buyback Rate is ranked higher than
90% of the 39 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.10 vs. AET: 1.90 )
AET' s 10-Year Share Buyback Rate Range
Min: 8.4   Max: -25.2
Current: 1.9

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 18.28
AET's Price/Tangible Book is ranked higher than
76% of the 50 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.00 vs. AET: 18.28 )
AET' s 10-Year Price/Tangible Book Range
Min: 0.88   Max: 23.45
Current: 18.28

0.88
23.45
Earnings Yield (Greenblatt) 11.80
AET's Earnings Yield (Greenblatt) is ranked higher than
89% of the 44 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.00 vs. AET: 11.80 )
AET' s 10-Year Earnings Yield (Greenblatt) Range
Min: 9   Max: 5139.1
Current: 11.8

9
5139.1
Forward Rate of Return (Yacktman) 18.20
AET's Forward Rate of Return (Yacktman) is ranked higher than
81% of the 37 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.48 vs. AET: 18.20 )
AET' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 1.5   Max: 54.4
Current: 18.2

1.5
54.4

Business Description

Industry: Health Care Plans » Health Care Plans
Compare:UNH, ESRX, WLP, HUM, CI » details
Traded in other countries:HE8.Germany,
Aetna Inc. Provides health care benefits. The Company offers traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid health care management services, Medicare Advantage and Medicare supplement plans, workers' compensation administrative services and health information technology products and services, such as Accountable Care Solutions. Health Care products consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative, basis and emerging businesses products and services, such as ACS, that complement and enhance its medical products. Medical products include point-of-service ("POS"), preferred provider organization ("PPO"), health maintenance organization ("HMO") and indemnity benefit ("Indemnity") plans. Medical products also include health savings accounts ("HSAs") and Aetna HealthFund, consumer-directed health plans that combine traditional POS or PPO and/or dental coverage, subject to a deductible, with an accumulating benefit account. The Company also offers Medicare and Medicaid products and services and other medical products, such as medical management and data analytics services, medical stop loss insurance, workers' compensation administrative services and products that provide access to our provider networks in select geographies. The Company also serves individual insureds, expatriates and, in certain markets, Medicare and Medicaid beneficiaries and providers. Its primary Commercial health care products are POS, PPO, HMO, HSA and Indemnity plans. Its personal health record provides members with online access to personal information, including personalized messages and alerts, detailed health history based on available claims data and voluntarily submitted information, and integrated information and resources to help members make informed decisions about their health care. The Company owns a number of trademarks and patents that are important to Aetna. Some of the trademarks include Aetna, as well as the corresponding Aetna design logo, Aetna Navigator, ActiveHealth, CareEngine, CarePass, Coventry, DocFind, HealthagenSM, Healthy Merits, Involve CareSM, iTriage, Medicity, Meritain Health, NeoCare SolutionsSM, PayFlex, Practice IQSM, Prodigy Health Group and WellmatchSM. The Company offers managed dental plans on an Insured and ASC basis.
» More Articles for AET

Headlines

Articles On GuruFocus.com
Cracking The Best Healthcare Dividend Stock Secrets Mar 02 2015 
Stocks Clocking Record Dividend Hike Feb 17 2015 
Has Gilead Sciences Been Able To Maintain Its Lead Run In The Face Of Competition? Jan 22 2015 
3 Strong ROC Stocks to Buy. Part 2 Jan 14 2015 
UNH: A Strong Candidate for Income and Capital Appreciation Dec 12 2014 
AmerisourceBergen a Key Player in the Pharma Industry Dec 10 2014 
The Stocks Warren Buffett May Have Bought During the Oct. 1 Sell-off Oct 14 2014 
Walmart Writing A New Chapter In Retail Business Oct 07 2014 
Despite Regulation, Transparency and Competition, Aetna Looks Competitive in the Industry Aug 29 2014 
Maintain a Healthy Portfolio with Aetna Mar 24 2014 


More From Other Websites
Humana reacts to a premium stabilization program in 4Q14 Mar 03 2015
An Obamacare ETF Keeps Rising Mar 02 2015
ObamaCare 'Success Story' Is ABronze Plan Trap Feb 28 2015
Aetna and Virtua Medical Group Expand Relationship with New Value-Based Accountable Care Agreement Feb 27 2015
Aetna Board of Directors Declares Quarterly Cash Dividend Feb 27 2015
This is the Fed's biggest economic headache Feb 27 2015
Business events scheduled for the coming month Feb 27 2015
Business events scheduled for the coming month Feb 27 2015
7.5M Obamacare Customers Face 255% Premium Increase If SCOTUS Strips Subsidies Feb 26 2015
Zacks Industry Outlook Highlights: UnitedHeath Group, Anthem, Aetna, Humana and Health Net - Press... Feb 26 2015
Health Insurers Find ObamaCare Headwinds Easing - Industry Outlook Feb 25 2015
Aetna Announces Appearance at Barclays Global Healthcare Conference 2015 Feb 25 2015
Aetna Announces Appearance at Barclays Global Healthcare Conference 2015 Feb 25 2015
Humana’s income rises 21% year-over-year in 4th-quarter 2014 Feb 25 2015
Zacks Industry Outlook Highlights: CIGNA, Anthem, Humana, UnitedHealth Group and Aetna - Press... Feb 25 2015
Analyst Stocks Hitting 52-Week Highs That Are Still a Buy Now Feb 25 2015
Aetna’s Private Equity Team Forms Money Management Firm Feb 24 2015
Aetna Announces Appearance at Raymond James 36th Annual Institutional Investors Conference Feb 24 2015
Aetna Announces Appearance at Raymond James 36th Annual Institutional Investors Conference Feb 24 2015
Aetna (AET) Stock Slumping Today Despite Deutsche Bank Price Target Increase Feb 24 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK